The Sales Oncology Liaison is responsible for maximizing the potential of product in key accounts, whilst staying within budget determined for the territory in France of: SE France PACA LANGEDOC ROUSSILLON. Key activities are delivering the selling messages, providing a high-level of customer service toward being a best in class assay provider, and solving challenging problems in a dynamic environment. He/she will have a track record in oncology sales (ideally breast cancer) and with existing contacts of private healthcare clinics/hospitals in this region, the individual will engage with physicians and KOLs to further develop sales in existing and new accounts. He/she will also build and maintain comprehensive understanding of his/her customer needs and develop key account records to manage these relationships. Reporting to the Country Manager or other such person as designated by the company, the Sales Oncology Liaison will join a small organization in start-up phase, have an entrepreneurial mind set with an ability to work autonomously, support the country manager with sales leads out of the region and have a willingness to travel where necessary. Furthermore, they will attend international and national conferences/meetings. Due to the complexity of medical oncology diagnostics, a person who has a medical/scientific background with an ability to analyze data, and who is well-organized, flexible and passionate about working with such products is most likely to succeed.
Genomic Health is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. The company's lead product, the Oncotype DX® breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS). In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test, the first multi-gene expression test developed for the assessment of risk of recurrence in patients with stage II and stage III disease. Genomic Health has a robust pipeline focused on developing tests to further optimize the treatment of breast, colon and prostate cancers, as well as the treatment of renal cancer. The company is based in Redwood City, California with European headquarters in Geneva, Switzerland. For more information, please visit, www.GenomicHealth.com. To learn more about Oncotype DX tests, visit: www.OncotypeDX.com and www.mybreastcancertreatment.org
All qualified applicants will receive consideration for employment without regard to race, sex, gender identity, color, religion, national origin, protected veteran status, or on the basis of disability.